Pacific biosciences of california stock.

٢١‏/٠٩‏/٢٠٢٣ ... In fact, the recent sale by Christian O. Henry was the biggest sale of Pacific Biosciences of California shares made by an insider individual in ...Stock Price Forecast. The 12 analysts offering 12-month price forecasts for Pacific Biosciences of California Inc have a median target of 10.50, with a high estimate of 19.00 and a low estimate of ... Pacific Biosciences of California Inc (PACB). Industry Medical Devices. Deal. This stock can be held in an Investment ISA and an Investment Account. Sell. $6.55.Ulysses Erickson. December 4, 2023. Company. Pacific Biosciences of California Inc (NASDAQ:PACB) has a beta value of 1.83 and has seen 0.81 million shares traded in the recent trading session. The company, currently valued at $2.37B, closed the recent trade at $8.86 per share which meant it lost -$0.02 on the day or -0.17% during that session.Institutional investors purchased a net $7.8 million shares of PACB during the quarter ended June 2019 and now own 98.90% of the total shares outstanding. This ...

Pacific Biosciences of California stock monthly and weekly forecasts. Skip to content. FORECST.COM 2023 – 2026 Stock Market Forecast PACB stock forecast for 2023 – 2027. Last updated: October 11, 2023. Are you interested in Pacific Biosciences of California, Inc. stocks prediction?Mar 3, 2023 · Pacific Biosciences of California Inc’s price is currently up 8.37% so far this month. During the month of March, Pacific Biosciences of California Inc’s stock price has reached a high of $10.00 and a low of $8.52. Over the last year, Pacific Biosciences of California Inc has hit prices as high as $14.20 and as low as $3.85. Get the latest PACB stock quote, charts, news, and other financial information to help you make more informed trading and investment decisions. See the company's earnings, …

Source: Shutterstock. We wouldn't blame Pacific Biosciences of California, Inc. NASDAQ:PACB) shareholders if they were a little worried about the fact that Christian O. Henry, the President recently netted about US$980k selling shares at an average price of US$10.12. That sale reduced their total holding by 29% which is hardly …Find real-time PACB - Pacific Biosciences of California Inc stock quotes, company profile, ... Pacific Biosciences of California Inc (NASDAQ:PACB) 8.89. Delayed Data. As of Dec 01

One such stock that merits attention is Pacific Biosciences of California Inc (NASDAQ:PACB). The stock, which is currently priced at 10.06, recorded a loss of 3.5% in a day and a 3-month decrease ...Checking In on Pacific Biosciences to See If It's Still a Good 'Idea'...PACB Employees of TheStreet are prohibited from trading individual securities. These recently downgraded names are displaying both quantitative and technica...Pacific Biosciences Of California. stock was originally listed at a price of $16.44 in Oct 27, 2010. If you had invested in Pacific Biosciences Of California stock …Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock. The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock. The opinion of analysts covering the stock has improved over the past four months.Track Pacific Biosciences of California Inc (PACB) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors

9.38M. AMZN. 146.74. +0.02%. 21.61M. View today's Pacific Biosciences of California stock price and latest PACB news and analysis. Create real-time notifications to follow any changes in the live ...

Raised approximately $201 million in gross proceeds in an upsized public offering of common stock in January 2023. ... Pacific Biosciences of California, Inc. Unaudited Condensed Consolidated Balance Sheets (in thousands) December 31, December 31, 2022. 2021. Assets. Cash and investments $ 772,318 $

PacBio announced record first-quarter revenue of $29 million, an 86% year-over-year increase and exactly what analysts expected. Meanwhile, the company recorded a net loss of $87.4 million -- or a ...Two of Cathie Wood's Ark Invest ETFs loaded up on shares of Pacific Biosciences of California (PacBio). PacBio is an innovative disruptor in the genetic sequencing market. However, the company ...Within the last quarter, Pacific Biosciences (NASDAQ:PACB) has observed the following analyst ratings: These 9 analysts have an average price target of $11.22 versus the current price of Pacific ...SAN DIEGO & MENLO PARK, Calif.--(BUSINESS WIRE)-- Illumina, Inc. (NASDAQ:ILMN) and Pacific Biosciences of California, Inc. (NASDAQ:PACB) today announced that they have mutually agreed to terminate their merger agreement, previously announced on November 1, 2018, under which Illumina would acquire Pacific Biosciences at a fully diluted enterprise value of approximately $1.2 billion in an all ...The notes will have a conversion price of $43.50 per share of the company's common stock, representing a 10% premium over Pacific Biosciences' share price as of the end of yesterday's trading session.

Let’s take a look at how Pacific Biosciences of California Inc’s stock performed this quarter. Earnings: $-0.28 per share, versus the consensus estimate of $-0.32 per share, according to AAII’s Stock Investor Pro, Refinitiv and I/B/E/S. Revenue: $39 million, versus $33 million in the same period one year ago.Asia Pacific; CORPORATE INQUIRIES ... California 6965 Lusk Boulevard San Diego, CA 92121 USA ... United Kingdom Rolling Stock Yard 188 York Way London, N7 9AS UK ... 24 Jan, 2023, 23:18 ET. MENLO PARK, Calif., Jan. 24, 2023 /PRNewswire/ -- Pacific Biosciences of California, Inc. (Nasdaq: PACB) ("PacBio") today announced that it has priced its previously ...Get the latest PACB stock quote, news, history and other vital information to help you with your stock trading and investing. See the performance outlook, earnings date, dividend yield, insider transactions and related research of Pacific Biosciences of California, Inc. (PACB) on NasdaqGS. Pacific Biosciences of California Inc. PACB (U.S.: Nasdaq) Pacific Biosciences of California Inc. View All companies. AT CLOSE 1:00 PM EST 11/24/23. $8.55 USD.

Stock analysis for Pacific Biosciences of California Inc (PACB:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Jan 25, 2023 · 24 Jan, 2023, 23:18 ET. MENLO PARK, Calif., Jan. 24, 2023 /PRNewswire/ -- Pacific Biosciences of California, Inc. (Nasdaq: PACB) ("PacBio") today announced that it has priced its previously ... PacBio highly accurate long-read sequencing provides the most comprehensive view of genomes, transcriptomes, and epigenomes. Learn how SMRT sequencing powers genomic insights in humans, plants, animals and microbes.Get a real-time Pacific Biosciences of California, Inc. (PACB) stock price quote with breaking news, financials, statistics, charts and more.As of November 17, 2023, 4:00 PM, CST, Pacific Biosciences of California Inc’s stock price was $8.40. Pacific Biosciences of California Inc is up 10.67% from its previous closing price of $7.59. During the last market session, Pacific Biosciences of California Inc’s stock traded between $7.44 and $7.68.Nov 15, 2023 · Get Pacific Biosciences of California Inc (PACB.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments Pacific Biosciences' Q3 2023 highlighted the adoption of their Revio system, particularly among new customers. Read why PACB stock is a Buy.Find the latest Pacific Biosciences of California, Inc. (PACB) stock quote, history, news and other vital information to help you with your stock trading and investing. Home. Mail; Search; News; Finance; ... Pacific Biosciences of California, Inc. (PACB) NasdaqGS - NasdaqGS Real-time price. Currency in USD. Add to watchlist. 8.88 +0.40 (+4.72%)Management will host a quarterly conference call to discuss its first quarter ended March 31, 2022, results today at 5:00 p.m. Eastern Time. Investors may listen to the call by dialing 866-652-5200, or if outside the U.S., by dialing 412-317-6060, and request to join the “PacBio Q1 Earnings Call.”. The call will be webcast live and will be ... 9.38M. AMZN. 146.74. +0.02%. 21.61M. View today's Pacific Biosciences of California stock price and latest PACB news and analysis. Create real-time notifications to follow any changes in the live ...

View the latest Pacific Biosciences of California Inc. (PACB) stock price, news, historical charts, analyst ratings and financial information from WSJ.

May 25, 2021 · Pacific Biosciences of California, Inc. (NASDAQ: PACB) is a California-based biotech firm founded in 2004. It is ranked seventh on our list of 10 best biotech stocks to buy according to Cathie Wood.

Discover Pacific Biosciences of California's earnings and revenue growth rates, forecasts, and the latest analyst predictions while comparing them to its industry peers. ... Independent Director exercised options and sold US$793k worth of stock May 29. The Pullback In Pacific Biosciences Makes For A Much More Interesting Opportunity …Pacific Biosciences of California stock monthly and weekly forecasts. Skip to content. FORECST.COM 2023 – 2026 Stock Market Forecast PACB stock forecast for 2023 – 2027. Last updated: October 11, 2023. Are you interested in Pacific Biosciences of California, Inc. stocks prediction?Pacific Biosciences' Q3 2023 highlighted the adoption of their Revio system, particularly among new customers. Read why PACB stock is a Buy.Get Pacific Biosciences of California (PACB) share price today, stock analysis, price valuation, performance, fundamentals, market cap, shareholding, ...The Pacific Biosciences of California stock prediction results are shown below and presented as a graph, table and text information. Pacific Biosciences of California stock forecasts are adjusted once a day based on the closing price of the previous trading day. The minimum target price for Pacific Biosciences of California …Valuation for Pacific Biosciences In 2023, the firm anticipates generating revenues in the range of $165 million to $180 million, reflecting a 29% to 40% increase. During the fourth quarter, 76 ...Pacific Biosciences of California Inc (NASDAQ: PACB) has seen a rise in its stock price by 10.74 in relation to its previous close of 6.52. However, the company has experienced a 1.55% gain in its stock price over the last five trading sessions. Zacks Investment Research reported 2023-10-31 that PacBio (PACB) witnesses strong revenue growth in ...One such stock that merits attention is Pacific Biosciences of California Inc (NASDAQ:PACB). The stock, which is currently priced at 10.06, recorded a loss of 3.5% in a day and a 3-month decrease ...A high-level overview of Pacific Biosciences of California, Inc. (PACB) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Aug 7, 2023 · Let’s take a look at how Pacific Biosciences of California Inc’s stock performed this quarter. Earnings: $-0.28 per share, versus the consensus estimate of $-0.32 per share, according to AAII’s Stock Investor Pro, Refinitiv and I/B/E/S. Revenue: $39 million, versus $33 million in the same period one year ago.

Nov 2, 2023 · Stock Quote. Price Change Change(%) Volume 52 Week High 52 Week Low ... Pacific Biosciences of California, Inc. 1305 O’Brien Drive, Menlo Park, CA 94025 [email protected]. Pacific Biosciences Of California. stock was originally listed at a price of $16.44 in Oct 27, 2010. If you had invested in Pacific Biosciences Of California stock …24 Jan, 2023, 23:18 ET. MENLO PARK, Calif., Jan. 24, 2023 /PRNewswire/ -- Pacific Biosciences of California, Inc. (Nasdaq: PACB) ("PacBio") today announced that it has priced its previously ...Pacific Biosciences of California Non-GAAP EPS of -$0.35 beats by $0.02, revenue of $27.35M beats by $0.06M SA News Thu, Feb. 16 Pacific Biosciences of California Q4 2022 Earnings PreviewInstagram:https://instagram. dog elon marsindependent financial advisors near mebest stock tracking websitesewer line protection plans MENLO PARK, Calif., Sept. 27, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq: PACB)(“Pacific Biosciences” or “PacBio”), a leading provider of high-quality, highly accurate sequencing platforms, today announced a partnership with The European Reference Genome Atlas (ERGA) consortium to support …View the latest Pacific Biosciences of California Inc. (PACB) stock price, news, historical charts, analyst ratings and financial information from WSJ. lyft stock share pricecan i trade forex with dollar100 ٢٠‏/١١‏/٢٠٢٣ ... PACB has a roughly average overall score of 41 meaning the stock holds a better value than 41% of stocks at its current price.The notes will have a conversion price of $43.50 per share of the company's common stock, representing a 10% premium over Pacific Biosciences' share price as of the end of yesterday's trading session. nyse cnx Pacific Biosciences of California, Inc. (PACB) NASDAQ: PACB · IEX Real-Time Price · USD. Add to Watchlist 8.55 +0.19 (2.27%) At close: Nov 24, 2023, 1:00 PM. 8.75 ... According to 10 stock analysts, the average 12-month stock price forecast for PACB stock stock is $11.8, which predicts an increase of 38.01%. The lowest target is …Christian O. Henry. Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflow, such as template ...PDF Version. MENLO PARK, Calif., Jan. 24, 2023 /PRNewswire/ -- Pacific Biosciences of California, Inc. (Nasdaq: PACB) ("PacBio") today announced that it intends to offer and sell $150.0 million of shares of its common stock in an underwritten public offering. PacBio also intends to grant the underwriters a 30-day option to purchase up to an ...